Modulating Antiangiogenic Resistance by Inhibiting the Signal Transducer and Activator of Transcription 3 Pathway in Glioblastoma

Determining the mechanism of treatment failure of VEGF signaling inhibitors for malignant glioma patients would provide insight into approaches to overcome therapeutic resistance. In this study, we demonstrate that human glioblastoma tumors failing bevacizumab have an increase in the mean percentage...

Descripción completa

Detalles Bibliográficos
Autores principales: de Groot, John, Liang, Ji, Kong, Ling-Yuan, Wei, Jun, Piao, Yuji, Fuller, Gregory, Qiao, Wei, Heimberger, Amy B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660053/
https://www.ncbi.nlm.nih.gov/pubmed/23013619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660053/
https://www.ncbi.nlm.nih.gov/pubmed/23013619

Ejemplares similares